Marksans Pharmaceuticals
Can exhibit a further up move or down move depending on further confirming price action at resistance line/ rounding bottom formation.
Fundamentally the stock is not in a bad position.
If price action breaks out in bullish manner, one can go long for medium to long term
After a downtrend (shown by red line), Share formed HAMMER followed by MARUBOZU (shown in box). RSI is also supporting price rise (marked by green arrow). All these things indicate that Share Price will go up.
I believe Marksans Pharma has the potential to give good returns in long term.
**Fundamental Analysis**
The stock gave great results on QOQ basis with from a loss of 8 lakhs to a profit of 14.5 crore thats good on every scale.
The only thing that concerns me is the P/E ratio which is way above the Industry average of 20.
**Credit Rating for Marksans Pharma...
Bullish cross over on weekly charts on Aroon indicator and indicates a change in trend . Close above 54-55 levels can see this stock touch 60-64 in short run and 84-100 in a years time.
Marksans Pharma Limited is a pharmaceutical holding company. The Company is engaged in the research, manufacturing and marketing of generic pharmaceutical formulations. The Company's product portfolio addresses various therapeutic segments, including Pain management, Cough and cold, Anti-diabetic, Cardiovascular system, Central nervous system, Antibiotic, Gastrointestinal, Anti-allergic and Miscellaneous. The Company undertakes research and development initiatives, and offers customer relationship management (CRM) services to global pharmaceutical companies. The Company has a manufacturing facility for the manufacture of oral solid tablets and soft gelatin capsules in Goa; a liquids/ointments/sachets manufacturing facility in Southport, the United Kingdom, and a solid oral dosages manufacturing facility in New York, the United States. It supplies products to approximately 20 countries. Its subsidiaries include Nova Pharmaceuticals Australasia Pty Ltd. and Marksans Pharma (UK) Limited.
This website uses cookies to ensure you get the best experience on our website. To learn more about cookies, including how to control cookies, please read our Cookies Policy.
MARKSANS
